President Donald Trump is canceling a contract that provides government funding to the University of California, San Francisco for research that issues fetal tissue harvested from elective abortions.
The Trump administration first focused its sights on the contract this past September, with the National Institute of Health (NIH) warning UCSF that its $2 million annual contract for fetal tissue research would be curtailed to 90 days and possibly canceled altogether.
Senior administration officials told The Daily Caller that the contract will be officially terminated Wednesday.
The cancelation stems from a 9-month U.S. Department of Health and Human Services (HHS) review of all research involving fetal tissue from elective abortions. HHS will also install ethics boards overseeing all extramural research involving fetal tissue.
WASHINGTON, DC – OCTOBER 25: AFP OUT U.S. President Donald Trump (L) shakes hands with Health and Human Services Secretary Alex Azar before announcing a plan to overhaul how Medicare pays for certain drugs during a speech at HHS headquarters October 25, 2018 in Washington, DC. Claiming that ‘global freeloading’ has driven up drug costs, Trump said his plan could save Medicare more than $17 billion over five years, with the cost of some drugs dropping by as much as 30 percent. (Photo by Chip Somodevilla/Getty Images)
An official explained to the Caller that the move is part of “a consistent charge to take a pro-life perspective on all policies.” (RELATED: VP Pence: ‘I’m Proud To Be Part Of A Pro-Life Administration’)
Fetal tissue is used in a number of research projects that seek to find cures or treatments for diseases such as HIV and pediatric cancer by creating humanlike immune systems in mice. However, pro-life groups say that the practice is unethical and gruesome because much of the fetal tissue used in research comes from aborted babies.